Search
for

    Did you mean Imiquimod 5% Cream?
    Glossary Imiquimod 5% Cream

    topical medication that stimulates immune response to treat skin conditions

    Imiquimod 5% Cream, also known as Aldara 5% cream, is a topical medication used to treat certain skin conditions, including actinic keratosis, superficial basal cell carcinoma, and external genital warts. It works by stimulating the immune system to release cytokines, which help the body fight off abnormal skin cells and infections.

    Related Terms

    Sort by

    Research 30 of 594

    1. Successful treatment of generalized discoid lupus erythematosus with imiquimod cream 5%: a case report and review of the literature. PubMed · 2014 · 24 citations
    2. Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study Veterinary Dermatology · 2006 · 76 citations
    3. Erosive Pustular Dermatosis of the Scalp Induced by Imiquimod Case reports in dermatological medicine · 2012 · 13 citations
    4. 1114 Study of long-term (15-day) imiquimod treatment and drug intervention in localized psoriasiform dermatitis model Journal of Investigative Dermatology · 2023
    5. A case of imiquimod-induced alopecia Journal of Dermatological Treatment · 2010 · 7 citations
    6. 12. Cancer Journal of Cutaneous Medicine and Surgery · 2003
    7. British Cosmetic Dermatology Group British Journal of Dermatology · 2015 · 1 citations
    8. Immunotherapies Reactions Weekly · 2010
    9. 8. Pathology Journal of Cutaneous Medicine and Surgery · 2003
    10. 6. Phototherapy, Photomedicine, and Pigmentary Disorders Journal of Cutaneous Medicine and Surgery · 2003
    11. Teledermatology: An updated overview of clinical applications and reimbursement policies Journal of The American Academy of Dermatology · 2018 · 1 citations
    12. Methotrexate/tacrolimus/voriconazole Reactions Weekly · 2018
    13. A case of imiquimod-induced alopecia Journal of Dermatological Treatment · 2009 · 6 citations
    14. Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis Journal of Pharmacy and Pharmacology · 2022 · 2 citations
    15. Persistierende Wundheilungsstörungen nach Lokaltherapie von Feldkanzerisierung des Capillitiums mit Imiquimod oder Diclofenac Aktuelle Dermatologie · 2014
    16. 1112 An innovative phase 1b trial demonstrating proof-of-pharmacology for two novel IRAK4-inhibitors using a local (Imiquimod) and systemic (LPS) driven immune response Journal of Investigative Dermatology · 2023
    17. Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management Advanced Pharmaceutical Bulletin · 2026
    18. Diclofenac/imiquimod Reactions Weekly · 2015
    19. Telogen effluvium with dysesthesia has lower B12 levels and may respond to B12 supplementation Journal of The American Academy of Dermatology · 2018
    20. 3. Pediatric Dermatology Journal of Cutaneous Medicine and Surgery · 2003
    21. 1. Medical Practice; Therapy; Adverse Reactions Journal of Cutaneous Medicine and Surgery · 2003
    22. 9. Immunology Journal of Cutaneous Medicine and Surgery · 2003
    23. Therapies The Journal of Dermatology · 2010
    24. Common Topical Medications Springer eBooks · 2018
    25. 11. Psoriasis/Acne and Disorders of Keratinization Journal of Cutaneous Medicine and Surgery · 2003
    26. 5. HIV, Fungal and Infectious Diseases Journal of Cutaneous Medicine and Surgery · 2003
    27. Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results Journal of The American Academy of Dermatology · 2017
    28. Hair growth promotion effect of cedrol cream and its dermatopharmacokinetics RSC Advances · 2018 · 11 citations
    29. Topical imiquimod—Be aware of the unexpected Journal of The American Academy of Dermatology · 2016 · 3 citations
    30. Erosive pustular dermatosis of the scalp after contact dermatitis from a prosthetic hair piece JAAD Case Reports · 2017 · 9 citations